By vgreene, 23 December, 2014 Consider 1st-line options<sup>2</sup> after pt education, risk/benefit counseling [CP]
By vgreene, 23 December, 2014 Behavior tx<sup>3</sup> is 1st-line for OAB: [S/B] bladder training/delayed voiding, bladder control strategies, PFMT, fluid mgmt, diet changes, wt loss, etc. May combine w/ drug tx<sup>2</sup> [C] if behavioral tx partially effective.
By vgreene, 23 December, 2014 Assess w/ hx,<sup>1</sup> exam, UA w/micro to exclude other disorders [CP]
By vgreene, 23 December, 2014 Not recommended for initial w/u in uncomplicated pts: urodynamics, cystoscopy, renal/bladder US. [CP]
By vgreene, 23 December, 2014 If dx unclear or more info needed: UCx, PVR, bladder diary, and/or sx questionnaire [CP]
By rray, 23 December, 2014 Increase PPI dosing<sup>19</sup> to bid or consider a switch to a different PPI<sup>20</sup> [C/L]
By rray, 23 December, 2014 If nocturnal sx, sleep disturbance, &/or variable schedules: consider dose-timing<sup>19</sup> adjustment &/or bid dosing [S/L]. Bedtime H2RA can be added prn to daytime PPI tx for nighttime sx, but tachyphylaxis may occur after several wks of use [C/L].